Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.22K Hold
69
﹤0.01% 1213
2025
Q4
$5.14K Hold
69
﹤0.01% 774
2025
Q3
$4.66K Hold
69
﹤0.01% 757
2025
Q2
$4.5K Hold
69
﹤0.01% 734
2025
Q1
$4.26K Hold
69
﹤0.01% 748
2024
Q4
$4.97K Hold
69
﹤0.01% 757
2024
Q3
$5.62K Hold
69
﹤0.01% 727
2024
Q2
$5.12K Hold
69
﹤0.01% 714
2024
Q1
$5.38K Hold
69
﹤0.01% 707
2023
Q4
$4.93K Hold
69
﹤0.01% 673
2023
Q3
$4.79K Hold
69
﹤0.01% 665
2023
Q2
$5.59K Hold
69
﹤0.01% 653
2023
Q1
$5.57K Hold
69
﹤0.01% 649
2022
Q4
$5.16K Hold
69
﹤0.01% 634
2022
Q3
$4K Hold
69
﹤0.01% 669
2022
Q2
$5K Hold
69
﹤0.01% 615
2022
Q1
$5K Hold
69
﹤0.01% 631
2021
Q4
$5K Buy
69
+15
+28% +$1.1K ﹤0.01% 628
2021
Q3
$4K Buy
+54
New +$4.05K ﹤0.01% 645

Other funds holding HOLX

McIlrath & Eck's HOLX Position: Q1 2026 in Review

McIlrath & Eck held its Hologic (HOLX) position steady in Q1 2026 at 69 shares worth $5.22K. The position accounts for ﹤0.01% of the portfolio, ranked #1213.

McIlrath & Eck first reported a position in HOLX in Q3 2021 and has held it in 19 quarters since. The position peaked at $5.62K in Q3 2024. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • McIlrath & Eck held 69 shares of Hologic worth $5.22K as of Q1 2026.
  • McIlrath & Eck left its Hologic share count unchanged in Q1 2026.
  • Hologic made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1213 holding.
  • McIlrath & Eck first reported a position in Hologic in Q3 2021 and has held it in 19 quarters since.
  • McIlrath & Eck's Hologic position peaked at $5.62K in Q3 2024.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.